Blood markers for brain health in children living with HIV
Part of Immune system & allergy, Infections clinical trials.
This study looks for chemical 'signatures' in blood that might be linked to brain problems in children with and without HIV. The goal is to help doctors find early signs of thinking or memory issues by using special blood tests, so children can get help sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is part of the ANRS Pediacam III cohort study, whether living with HIV or not.
- Your child took part in the PediacamDev study that checks brain and thinking development.
- Your child has results from the KABC-II thinking test.
- There are stored blood samples (plasma) that have never been thawed and are enough for the study (at least half a teaspoon).
- Your child had follow-up visits at about 6 months, 12 months, and 9 years of age (108 months) as part of the cohort.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research compares the immune system in the gut lining, spinal fluid, lymph nodes, and blood between people living with HIV and people not living with HIV. Results may help scientists understand how immunity works and how it differs with HIV.
This study looks at thinking and memory skills in teenagers living with HIV. It compares them to HIV-negative teens to see how HIV and its treatment affect the brain.
This study looks at how thinking and memory change over time in adults with HIV and compares them with adults without HIV. Researchers will do regular visits and brain/cognitive testing to understand what affects thinking and memory and to learn what might help.
This study uses PET and MRI scans, plus blood tests and memory/thinking questionnaires, to understand what drives brain problems in people living with HIV even during treatment. It may help researchers learn why symptoms happen and how treatment relates to brain function.
This research study collects blood cells from people recently diagnosed with HIV who haven't started HIV medicines yet. Researchers use these samples to understand how HIV affects the immune system and develop better treatments.
This study looks at how well clinics can monitor the development of young children who were exposed to HIV, and whether it is worth the cost. It may help ensure these children get the support they need early.
Hear when a new HIV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.